International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly
INR-Cap pilote
2 other identifiers
interventional
31
1 country
1
Brief Summary
The main objective of this study is to evaluate, for a 6-month observation period, the concordance in terms of clinical decision making concerning therapeutic adjustment as determined by a weekly capillary International Normalised Ratio (INR) monitoring strategy versus the usual strategy in a population of dependent elderly people in nursing homes, treated with anti-vitamin K (AVK).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2015
CompletedFirst Posted
Study publicly available on registry
November 25, 2015
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 13, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2016
CompletedNovember 19, 2025
August 1, 2016
6 months
November 19, 2015
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Is the capillary INR concordant with the venous INR ? yes/no
Primary Outcome Measure as stated in protocol: Clinical concordances and clinical discrepancies between the capillary INR and venous INR every time they are concomitant
6 months
Secondary Outcomes (5)
The number of thromboembolic events per patient
6 months
The number of bleeding events per patient
6 months
The number of thromboembolic or bleeding events per patient
6 months
Coefficient of variation for capillary INR measures per patient
6 months
Time in therapeutique range (days)
6 months
Study Arms (1)
The study population
EXPERIMENTALThe clinical phases of this study will be held in the nursing home (EHPAD; principal building + 2 annexes) of Pont-Saint-Esprit, located in France. Patients are elderly dependents treated by anti-vitamin K for more than 6 months.
Interventions
We will be using the CoagucheckXSR device for capillary INR measures performed by nurses every 7 days during the 6 months of the study, plus after related intercurrent events. If capillary INR is \<2 or \>3 (with a tolerance of 1.9 to 3.1 given the margin of measurement inaccuracy of the coagulometer), then a classic venous measure is performed. If both tests agree, adaptation of treatment as indicated. If slightly discordant results, then the INR values are considered discordant and the decision to adjust the treatment dose and the next monitoring date for venous INR is made based on the value of the venous INR, according to the predefined protocol. If clinically significant discordance (\> 0.3), a venous INR is reperformed within 24 hours and if the discrepancy persists, dose adjustment is made according to the venous INR and the predefined protocol. If capillary INR is \> 4, then verification by venous measure and refer to general practitioner.
Eligibility Criteria
You may qualify if:
- The patient resides at the establishment for the dependent elderly (nursing home (EHPAD)) in Pont-Saint-Esprit, France
- The patient must be insured or beneficiary of a health insurance plan
- The patient treated with vitamin K antagonist for over six months
- The patient must have given his/her informed and signed consent
- For adults under guardianship, the legal guardian must have given free and informed consent and signed the consent
You may not qualify if:
- The patient is under judicial protection
- The general practitioner in charge of the patient at the EHPAD does not want to participate in the study
- It is impossible to correctly inform the patient, or his/her legal guardian
- The patient, or his/her legal guardian, refuses to sign the consent
- The patient is participating in another interventional study, or has participated in another interventional study within the past three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EHPAD de l'Hôpital de Pont Saint Esprit
Pont-Saint-Esprit, 30130, France
Related Publications (1)
Sikirdji C, Costa D, Alonso S, Clape JF, Amouyal M, de Waziere B, Fabbro-Peray P. Assessment of agreement and time in therapeutic range of capillary versus venous international normalised ratio in frail elderly people in a nursing home. Intern Med J. 2019 Nov;49(11):1442-1446. doi: 10.1111/imj.14626.
PMID: 31713344RESULT
Study Officials
- STUDY DIRECTOR
Chloé Sikirdji, Interne
Centre Hospitalier Universitaire de Nîmes
- PRINCIPAL INVESTIGATOR
Jean-François Clape, MD
Centre Hospitalier Universitaire de Nîmes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2015
First Posted
November 25, 2015
Study Start
February 1, 2016
Primary Completion
August 13, 2016
Study Completion
August 13, 2016
Last Updated
November 19, 2025
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share